Registry of Cardio/Neurovascular Anesthesia Including the Database of Biological Signals During Anesthesia, Preoperative Assessment and Prognosis in Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorYonsei University

About this trial

The purpose of this study is to establish a registry database for patients undergoing anesthesia for cardiovascular surgery or procedures in our operating or hybrid room. The following information will be collected:

1. Preoperative patient assessment 2. All monitored perioperative biosignal data 3. Intraoperative and immediate postoperative hemodynamic information, input/output balance, and medication usage 4. Short- and long-term prognosis from electronic medical records This database will be used to develop a vigilant monitoring system that integrates multiple biosignal data simultaneously, contributing to the improvement of anesthesia care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults age 19 and older

Patients scheduled for anesthesia at a cardiovascular hospital for cardiovascular surgery or procedures

Disqualifiers

None

Trial population

Patients undergoing cardio/neurovascular surgery or procedure

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

10,000 Participants
are grouped into 1 trial group
Group A: Anesthesia for cardiovascular surgery or procedure

Trial outcomes

Primary outcomes

1

all cause mortality

All-cause mortality within one year after surgery

Time frame
one year after surgery

Secondary outcomes

1

Postprocedural myocardial infarction

Defined by an increase in CK-MB or cardiac troponin (cTn) levels.

Time frame
within 2days after surgery
2

Acute kidney injury

The definition of AKI refers to the Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group's KDIGO Clinical Practice Guideline for Acute Kidney Injury.

Time frame
within 7days after surgery
3

surgical re-exploration

require a return to the operating room for bleeding with or without tamponade, graft occlusion, valve dysfunction, or other cardiac reason

Time frame
within 30 days (±3 days) after surgery
4

deep sternal wound infection

infection involving muscle, bone, or mediastinum requiring operative intervention

Time frame
within 30 days (±3 days) after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.